Nine Masts Capital »

Altimmune shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $37k 12k 3.08

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Altimmune

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Susquehanna International
Millennium Management
Geode Capital Management
Alyeska Investment Group
Two Sigma Investments
Nuveen
Goldman Sachs Group
Dimensional Fund Advisors
Citadel Advisors
Marshall Wace

View all funds holding Altimmune